Ticker: CBPO, Company: China Biologic Products, Inc., Type: 10-Q, Date: 2014-08-05, XBRL Interactive Financials
Original SEC Filing: Click here
Webplus: CBPO/20140805/10-Q/1/000.htm SEC Original: v384097_10q.htm
Webplus: CBPO/20140805/10-Q/2_EX-3.1/000.htm SEC Original: v384097_ex3-1.htm
STATE OF DELAWARE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CHINA BIOLOGIC PRODUCTS, INC. Corporation China Biologic Products, Inc., a corporation organized and existing under the laws of the State of Delaware (the “ A. The name of the Corporation is China Biologic Products, Inc. The original Certificate of Incorporation of the Corporation was filed with the Secretary of
Webplus: CBPO/20140805/10-Q/3_EX-3.2/000.htm SEC Original: v384097_ex3-2.htm
THIRD AMENDED AND RESTATED BYLAWS OF CHINA BIOLOGIC PRODUCTS, INC. (the “Corporation”) Adopted on June 20, 2014 ARTICLE I OFFICES Registered Office Certificate of Incorporation Section 1.01. Other Offices Board of Directors Board Section 1.02. ARTICLE II MEETINGS OF STOCKHOLDERS Annual Meeting Section 2.01. Voting List Section 2.02. Special Meeting Section 2.03. Advance Notice Procedures Section 2.04. Advance Notice of
Webplus: CBPO/20140805/10-Q/4_EX-31.1/000.htm SEC Original: v384097_ex31-1.htm
CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such
Webplus: CBPO/20140805/10-Q/5_EX-31.2/000.htm SEC Original: v384097_ex31-2.htm
CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements
Webplus: CBPO/20140805/10-Q/6_EX-32.1/000.htm SEC Original: v384097_ex32-1.htm
OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer
Webplus: CBPO/20140805/10-Q/7_EX-32.2/000.htm SEC Original: v384097_ex32-2.htm
OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang Chief Financial Officer (Principal Financial Officer)
Company Information:
Ticker: CBPO, Company: China Biologic Products, Inc., Type: 10-Q, Date: 2014-08-05, XBRL Interactive FinancialsCIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING
BEIJING 100125
-
- Forum
- Topics
- Last Post
Leave A Comment
You must be logged in to post a comment.